share_log

6-K: Report of foreign private issuer (related to financial reporting)

6-K: Report of foreign private issuer (related to financial reporting)

6-K：外國發行人報告（業績相關）
美股SEC公告 ·  10/31 17:01

Moomoo AI 已提取核心訊息

On October 31, 2024, NeuroSense Therapeutics Ltd., a foreign private issuer, announced the signing of a Standby Equity Purchase Agreement with YA II PN, LTD., a Cayman Islands exempt limited partnership also known as Yorkville. Under the terms of the agreement, NeuroSense has the option, but no obligation, to sell up to $30 million of its ordinary shares to Yorkville over a 36-month period. The sale price for the shares will be set at 97% of the lowest daily VWAP on the Nasdaq Stock Market over a specified three-day period following the company's notice to Yorkville. Additionally, NeuroSense has issued 224,697 ordinary shares to Yorkville as a commitment fee and paid a $25,000 structuring fee. The agreement stipulates that Yorkville's ownership cannot exceed...Show More
On October 31, 2024, NeuroSense Therapeutics Ltd., a foreign private issuer, announced the signing of a Standby Equity Purchase Agreement with YA II PN, LTD., a Cayman Islands exempt limited partnership also known as Yorkville. Under the terms of the agreement, NeuroSense has the option, but no obligation, to sell up to $30 million of its ordinary shares to Yorkville over a 36-month period. The sale price for the shares will be set at 97% of the lowest daily VWAP on the Nasdaq Stock Market over a specified three-day period following the company's notice to Yorkville. Additionally, NeuroSense has issued 224,697 ordinary shares to Yorkville as a commitment fee and paid a $25,000 structuring fee. The agreement stipulates that Yorkville's ownership cannot exceed 4.99% of NeuroSense's outstanding shares. The transaction is contingent upon the SEC declaring effective a registration statement for the shares involved. The shares are being offered under an exemption from registration requirements and are not to be sold or offered in the U.S. without registration or an applicable exemption. The agreement includes customary representations, warranties, and conditions.
2024年10月31日，外國私募股權公司NeuroSense Therapeutics Ltd.宣佈與開曼群島免稅有限合夥企業YA II PN，LTD.（又稱爲Yorkville）簽署了一份備用股權購買協議。根據協議規定，NeuroSense有權但無義務在36個月內向Yorkville出售最多3000萬美元的普通股。股票的銷售價格將設定爲公司向Yorkville發出通知後的指定三天期間納斯達克股市最低日均加權平均價的97%。此外，NeuroSense已向Yorkville發行了224,697股普通股作爲承諾費，支付了25,000美元的結構費。協議規定Yorkville的持股比例不能超過NeuroSense已發行股票的4.99%。交易取決於SEC對涉及的股票註冊聲明有效。這些股票是根據免於註冊要求的例外條件提供的，未經註冊或適用例外情況，不得在美國銷售或報價。協議包括慣例的陳述、保證和條件。
2024年10月31日，外國私募股權公司NeuroSense Therapeutics Ltd.宣佈與開曼群島免稅有限合夥企業YA II PN，LTD.（又稱爲Yorkville）簽署了一份備用股權購買協議。根據協議規定，NeuroSense有權但無義務在36個月內向Yorkville出售最多3000萬美元的普通股。股票的銷售價格將設定爲公司向Yorkville發出通知後的指定三天期間納斯達克股市最低日均加權平均價的97%。此外，NeuroSense已向Yorkville發行了224,697股普通股作爲承諾費，支付了25,000美元的結構費。協議規定Yorkville的持股比例不能超過NeuroSense已發行股票的4.99%。交易取決於SEC對涉及的股票註冊聲明有效。這些股票是根據免於註冊要求的例外條件提供的，未經註冊或適用例外情況，不得在美國銷售或報價。協議包括慣例的陳述、保證和條件。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間